Bumper Offer - Urjas oil Just @ Rs. 1
Amlovas M 50 Tablet PR is a commercial drug that is prescribed in the form of Tablet. Amlovas M 50 Tablet PR also has some secondary and off-label uses. These are listed below.
The correct dosage of Amlovas M 50 Tablet PR depends on the patient's age, gender, and medical history. The condition it has been prescribed for, and the route of administration also determine the right dosage. This information has been provided in detail in the dosage section.
The most common side effects of Amlovas M 50 Tablet PR are Slow heart rate (pulse). While these are the most often observed Amlovas M 50 Tablet PR side effects, there are can be others also. These have been listed below. Usually, these side effects of Amlovas M 50 Tablet PR go away soon, and do not persist beyond the duration of the treatment. However, if these continue for a longer time, consult your doctor right away.
Amlovas M 50 Tablet PR's effect during pregnancy is Severe and Mild while nursing. In addition, Amlovas M 50 Tablet PR's effects on the liver, heart and kidney are discussed below in the Amlovas M 50 Tablet PR related warnings section.
Amlovas M 50 Tablet PR can cause adverse effects in certain medical conditions. It is strongly recommended to avoid Amlovas M 50 Tablet PR in conditions like Low Blood Pressure (Hypotension), Coronary Artery Disease (CAD), Liver Disease. The section on Amlovas M 50 Tablet PR contraindications lists all such conditions.
Drug interactions for Amlovas M 50 Tablet PR have been reported in the medical literature. A complete list of these interactions is given below.
You should also be aware that Amlovas M 50 Tablet PR is not safe while driving, and is not addiction.
Amlovas M 50 Tablet PR is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
Based on research, the following side effects have been observed when Amlovas M 50 Tablet PR is used -
Moderate
Mild
Common
Is the use of Amlovas M 50 Tablet PR safe for pregnant women?
Amlovas M has many dangerous side effects in pregnant women. If you are pregnant, do not consume Amlovas M without medical advice.
Is the use of Amlovas M 50 Tablet PR safe during breastfeeding?
Amlovas M has been seen to have minimal side effects on breastfeeding women.
What is the effect of Amlovas M 50 Tablet PR on the Kidneys?
Using Amlovas M does not have any harmful effects on kidneys.
What is the effect of Amlovas M 50 Tablet PR on the Liver?
Amlovas M may have mild side effects on the liver. Most people will never see any effect on the liver.
What is the effect of Amlovas M 50 Tablet PR on the Heart?
Very few cases of side effects of Amlovas M on the heart have been reported.
Amlovas M 50 Tablet PR should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Amlovas M 50 Tablet PR unless your doctor advises you to do so -
Is this Amlovas M 50 Tablet PR habit forming or addictive?
No, you will not get addicted to Amlovas M 50 Tablet PR.
Interaction between Food and Amlovas M 50 Tablet PR
Some foods when eaten with Amlovas M 50 Tablet PR can alter the onset of actions. Discuss this with your doctor.
Interaction between Alcohol and Amlovas M 50 Tablet PR
Consult your doctor before consuming alcohol while taking Amlovas M 50 Tablet PR as it can have severe side effects.
This medicine data has been created by -
B.Pharma, Pharmacy
7 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Norvasc® (amlodipine besylate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 540, 549, 550
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 147-148
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Lopressor (metoprolol tartrate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 148-149
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 847-850
